HOME >> BIOLOGY >> NEWS
Pacemaker therapy halves heart failure deaths

Using specialized pacemakers to recharge the weakened hearts of heart failure patients can halve the death rate from the disease and reduce hospitalizations by nearly a third, a Johns Hopkins study has found.

Results of the study, which analyzed clinical trials of pacemaker therapy for heart failure involving a total of 1,634 patients, are published in the Feb. 12 issue of The Journal of the American Medical Association.

"The devices range in cost from $20,000 to $50,000," says lead author David J. Bradley, M.D., Ph.D., a cardiology fellow. "These specialized pacemakers have been known to improve the quality of life for heart failure patients, but whether they also save lives had been unclear."

Heart failure accounts for more than 700,000 hospitalizations among Medicare beneficiaries every year, Bradley says. In the year 2000, hospitalization charges amounted to $14 billion. Half of deaths among these patients are caused by progressive cardiac dysfunction, which pacemakers help correct by stimulating the heart muscle to contract, pumping blood to the body.

Heart failure, which affects nearly 5 million people in the United States, is a condition in which the heart can't pump enough blood to the body's other organs. This can result from assorted problems including heart attack, high blood pressure or heart valve disease. The "failing" heart keeps working but not as efficiently as it should. People with heart failure can't exert themselves because they become short of breath and tired.

Advances in technology have increased the number of people diagnosed with heart failure each year, says senior author Neil R. Powe, M.D., M.P.H., director of Johns Hopkins' Welch Center for Prevention, Epidemiology and Clinical Research. About 550,000 new patients are diagnosed annually, he says.

"We can often save heart attack patients with drugs like thrombolytics or with angioplasty, but they survive with weakened hearts, and ofte
'"/>

Contact: John Lazarou
jlazaro1@jhmi.edu
410-502-8902
Johns Hopkins Medical Institutions
11-Feb-2003


Page: 1 2

Related biology news :

1. Researchers Discover Novel Gene Family Responsible For Pacemaker Activity In Brain And Heart
2. Protecting the Beat Of Life: Test Center Studies Interaction Between Pacemakers & Electronic Article Surveillance Systems
3. Evaluation Of The Two Types Of Cardiac Pacemakers Indicates Only Modest Differences In Value
4. Targeted therapy knocks out pediatric brain cancer in mice
5. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
6. Columbia research to examine gene influence on severity of peridontal disease, therapy response
7. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
8. The search for a kinder, gentler chemotherapy
9. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
10. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
11. Gene changes linked to increased eye pressure may have implications for glaucoma therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/19/2017)... 19, 2017 The global military ... is marked by the presence of several large global ... by five major players - 3M Cogent, NEC Corporation, ... for nearly 61% of the global military biometric market ... the global military biometrics market boast global presence, which ...
(Date:4/13/2017)... Calif. , April 13, 2017 UBM,s ... York will feature emerging and evolving technology ... Both Innovation Summits will run alongside the expo portion ... speaker sessions, panels and demonstrations focused on trending topics ... largest advanced design and manufacturing event will take place ...
(Date:4/11/2017)... Apr. 11, 2017 Research and Markets has ... report to their offering. ... The global eye tracking market to grow at a CAGR of ... Eye Tracking Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
Breaking Biology News(10 mins):
(Date:7/20/2017)... ... July 20, 2017 , ... Crucial ... trial sites and study participants truly unified. TrialKit, a native mobile app, empowers ... Part 11) research studies entirely on mobile devices. With TrialKit, clinical researchers can ...
(Date:7/18/2017)... ... July 18, 2017 , ... ... States Patent and Trademark Office for its Patent Applications 14/858,857 and 13/669,785 both ... of these patent applications further expand the protection of G-CON’s R&D investments and ...
(Date:7/17/2017)... ... July 17, 2017 , ... ... device testing capabilities to encompass the full series of ISO 80369 standard test ... fittings for medical device and drug delivery systems. With this recent expansion, Whitehouse ...
(Date:7/17/2017)... Linda, Ca (PRWEB) , ... July 17, 2017 ... ... heterogeneous and are characterized by a wide range of overlapping clinical features. The ... of discovery in the field of NDD research and testing. , However, ...
Breaking Biology Technology:
Cached News: